As June drew to a close, Swissray International announced that Marconi Health Care Products (HCP) would market and service Swissray’s line of direct digital radiography (ddR) systems in the U.S., supplementing an existing distribution agreement
As June drew to a close, Swissray International announced that Marconi Health Care Products (HCP) would market and service Swissray’s line of direct digital radiography (ddR) systems in the U.S., supplementing an existing distribution agreement with Hitachi Medical. The Marconi sales force had been trained, marketing had begun, and Swissray was enthusiastic about the prospect of broadened acceptance of digital radiography through a concerted effort by HCP.
In the wake of Marconi Medical’s agreement to be acquired by Philips, however, the question of what will become of the deal with Swissray rears its head. Rex Harmon, vice president of global marketing, sees nothing but upside in regard to digital radiography.
“Philips is clearly in transition,” Harmon said. “It has distanced itself from the Trixell (digital detector) plate, because Trixell cannot produce these plates in volume.”
Alternatively, HCP might be spun off, Harmon speculates. Either way, Swissray wins.
“This is a terrific opportunity to divert a revenue stream toward our product and away from CR and film,” he said.
Traditionally, HCP has sold consumables, particularly medical film. Over the past several years, however, the division has been steadily adding capital equipment. This transition began with laser imagers a decade ago, according to Larry Miller, vice president and general manager of HCP, and includes Fuji, Agfa, and Kodak computed radiography systems and, now, Swissray ddR systems.
“It has been a natural progression,” Miller said. “We have been growing into the digital world as the film manufacturers have migrated there. But we still have a foot in the analog world. Two-thirds of our gross margin and revenue come from film.”
HCP holds the greatest potential of any vendor for increasing ddR sales, Harmon said, because of its extensive customer base, its commanding position in the radiography film market, and a corporate strategy to move toward digital imaging. Marconi’s negotiations to sell the medical business added a sense of urgency to the talks between HCP and Swissray, he said.
“We thought once a change of control was announced, there would be a long period of waiting for things to shake out,” Harmon said. “We wanted to jump right in and be in the middle of it.”
Can AI Facilitate Improved Dual-Energy X-Ray Screening for Patients at High Risk of Osteoporosis?
June 28th 2024Out of 315 patients identified by artificial intelligence (AI) as being at high risk for osteoporosis, subsequent screening with dual-energy X-ray absorptiometry (DXA) in a randomized controlled trial revealed new-onset osteoporosis in 237 patients.
FDA Clears Mobile C-Arm Device Designed for Complex Vascular Procedures
June 17th 2024Offering a combination of intuitive user-friendly controls and enhanced imaging, the Zenition 90 Motorized C-arm reportedly facilitates workflow efficiencies and bolsters visualization for complex vascular procedures, cardiac interventions, and other clinical procedures.
Qure.ai to Debut Multimodality AI Platform for Lung Cancer Imaging at ASCO 2024
May 29th 2024In addition to detecting missed lung nodules on X-rays, the AI-powered Qure.ai lung cancer continuum platform reportedly automates lung nodule measurement on CT scans and facilitates multimodality reporting.